Tapemark Revenue and Competitors
Estimated Revenue & Valuation
- Tapemark's estimated annual revenue is currently $13.9M per year.
- Tapemark's estimated revenue per employee is $201,000
Employee Data
- Tapemark has 69 Employees.
- Tapemark grew their employee count by -13% last year.
Tapemark's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller | Reveal Email/Phone |
2 | VP, Research and Development | Reveal Email/Phone |
3 | Director Analytical Services | Reveal Email/Phone |
4 | Manufacturing Operations,Safety and Security Manager | Reveal Email/Phone |
5 | Quality Manager | Reveal Email/Phone |
6 | Operations Manager | Reveal Email/Phone |
7 | Senior Quality Control Manager | Reveal Email/Phone |
8 | Front Desk Coordinator | Reveal Email/Phone |
9 | Production Supervisor | Reveal Email/Phone |
10 | Sr. Production Planner | Reveal Email/Phone |
Tapemark Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.9M | 69 | -13% | N/A | N/A |
#2 | $110.3M | 549 | -3% | N/A | N/A |
#3 | $14.1M | 70 | 1% | N/A | N/A |
#4 | $1051.4M | 5231 | -5% | N/A | N/A |
#5 | $55.9M | 278 | 22% | N/A | N/A |
#6 | $50.3M | 250 | N/A | N/A | N/A |
#7 | $2.2M | 22 | 214% | N/A | N/A |
#8 | $1.4M | 7 | -87% | N/A | N/A |
#9 | $68.1M | 339 | 17% | N/A | N/A |
#10 | $19.5M | 97 | 0% | N/A | N/A |
What Is Tapemark?
Here at Tapemark, we are the foremost leaders and innovators for development and manufacturing in transdermal and oral thin film drug delivery. No, really, we are. We offer a fully-integrated solution. Our services include formulation, optimization, blending, coating, converting, primary packaging, secondary cartoning, and kitting to commercially manufacture transdermal and oral thin film drugs. We have successful experience with NDA, ANDA, and 505(b)2 FDA approvals including those for Schedule II-V controlled substances. As a team of subject matter experts and craftsmen, we nurture our client's pharmaceutical formulation, develop it, scale it, and guide it through the FDA approval process. Tapemark is comprised of pioneering chemists, researchers, and engineers. As world experts in transdermal and oral thin film drug delivery, we offer full project management services to keep projects ahead of milestones and never behind. Tapemark has significant experience launching NDA and ANDA drugs to offer our clients the most hands-on and successful partnership in the CDMO space. Tapemark is known for its superior, truly unmatched, state-of-the-art equipment. Since the beginning, our investment has been laser-focused on owning and operating a 150,000-square-foot facility that cannot be beat in the industry. We are devoted to the industry's brightest people and most advanced equipment. We know what works. We know what doesn't. And we know where we can innovate and deliver for efficient FDA approvals and progressive timelines. The Tapemark team is powered, staffed, and driven to help clients move faster, better, and with unrivaled quality to benefit the patient and improve compliance. Our pharmaceutical products perform in the clinic and surpass FDA standards. Tapemark is privately-held and based in West St. Paul, Minnesota, with multiple facilities in a campus environment. The company services the pharmaceutical, medical, and consumer products markets.
keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,PharmaceuticalsN/A
Total Funding
69
Number of Employees
$13.9M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tapemark News
Tapemark, Acrux Limited Nitto Denko Corporation Skinvisible Pharmaceuticals, Inc. Mylan Pharmaceuticals Inc. Pocono Coated Products LLC
... tesa Labtec, Tapemark, Prestige, MonoSol, BioDelivery, Arx, ZIM, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx Corp & APR etc.
Prosolus Inc. Samyang Holdings Corporation; Tapemark; Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd); tesa SE (Beiersdorf AG); Teva...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.8M | 96 | 5% | N/A |
#2 | $15.7M | 143 | 7% | N/A |
#3 | $15M | 151 | 12% | N/A |
#4 | $48.8M | 390 | 2% | N/A |